Drug firm Sharon Bio-Medicine today said its net profit rose by 23.65% to Rs 11.97 crore for the quarter ended September 30, 2012 on back of robust sales.
The company had posted a net profit of Rs 9.68 crore for the quarter ended September 30, 2011, Sharon Bio-Medicine said in a filing to BSE.
Net sales of the company also rose to Rs 216.68 crore for the quarter under consideration from Rs 174.36 crore in the corresponding period of previous fiscal.
The company manufactures Intermediates, active pharmaceutical ingredients (APIs) and finished dosages, Sharon Bio-Medicine said.
Shares of Sharon Bio-Medicine today closed at Rs 358 on BSE, down 0.68% from their previous close.